[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Brazil

October 2022 | 30 pages | ID: ADCDC87C54EEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Analgesics is the largest category within OTC products, and consumption is mainly related to general pain and fever, and to relieve hangover symptoms caused by excessive consumption of alcoholic beverages. Thus, the most consumed medications are those that have more than one ingredient in their formula, and consequently they are classified under adult combination products – analgesics. This category is expected to continue to account for almost half of sales of analgesics in 2022. The increase i...

Euromonitor International's Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN BRAZIL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Headaches, muscle aches and hangovers explain the high consumption of analgesics
Lack of raw materials and supply issues hold back growth, which could have been higher
Acquisitions reinforce Hypera’s portfolio, and Reckitt Benckiser bets on analgesics
PROSPECTS AND OPPORTUNITIES
Inflationary pressure should not harm sales of analgesics in the short term
Multinationals may divest their OTC divisions, while negotiations could form a giant in the national pharmaceutical industry
Expectation of faster-acting products and more flexibility in distribution
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN BRAZIL
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
New ways of consuming vitamins emerge, and probiotics are highlighted in preventative care
Spin-offs, mergers and acquisitions mark the Brazilian competitive landscape
The advance of pharmacies continues, but could be pressured by the entry of a new distribution channel
Open health, personalisation and logistical issues emerge as important shifts on the horizon
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources


More Publications